CSIMarket Company Name, Ticker, Industry, else..


Organovo Holdings Inc   (NASDAQ: ONVO)
Other Ticker:  
 

Organovo Holdings Inc

ONVO's Fundamental analysis



Looking into Organovo Holdings Inc growth rates, revenue grew by 380 % in the third quarter of 2024 from the same quarter a year ago. Ranking at No. 200

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.05 %

Organovo Holdings Inc net loss decreased from $-4 millions, to $-3 millions in third quarter of 2024,

• More on ONVO's Growth


Organovo Holdings Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Organovo Holdings Inc PEG ratio is at -0 Organovo Holdings Inc realized cash reduction of $ -4.29 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
0.37
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 33.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.99.


• More on ONVO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,325
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 2.74
 Tangible Book Value (Per Share $) 0.24

Organovo Holdings Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Organovo Holdings Inc PEG ratio is at -0 Organovo Holdings Inc realized cash outflow of $ -4.29per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
0.37
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 33.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.99.

Organovo Holdings Inc Price to Book Ratio is at 8.43 lower than Industry Avg. of 75344.2. and higher than S&P 500 Avg. of 0.01

• More on ONVO's Valuation

•  Market Capitalization (Millions $) 3
•  Shares Outstanding (Millions) 2
•  Employees 40
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) -6
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 2,325
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 2.74
•  Tangible Book Value (Per Share $) 0.24

•  Market Capitalization (Millions $) 3
•  Shares Outstanding (Millions) 2
•  Employees 40
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) -6
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 0.72
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 9.56
•  Asset Turnover Ratio (TTM) 0.01
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com